共 50 条
- [25] Drug-eluting stents for the treatment of left main coronary artery disease with sirolimus, paclitaxel, zotarolimus, tacrolimus-eluting stent and EPIC capture stent: Multicenter registry in Asia AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 101L - 101L
- [26] Evaluation of a tacrolimus-eluting coronary stent graft for treatment of saphenous vein graft lesions: Procedural and 6-month follow-up results of the EVIDENT trial AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 183L - 183L
- [27] Drug-eluting stents for the treatment of very long coronary artery stenosis: A comparison with sirolimus, paclitaxel, zotarolimus, tacrolimus-eluting stent and EPC capture stent: Multicenter registry in Asia AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 157L - 157L
- [28] 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions The SPIRIT II Trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions) JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1190 - 1198
- [29] Evaluation of Effectiveness and Safety of Everolimus Eluting Stent System (XIENCE V) in the Treatment of Coronary Artery Lesions EUROPEAN JOURNAL OF THERAPEUTICS, 2021, 27 (02): : 149 - 157
- [30] Evaluation of Effectiveness and Safety of Everolimus Eluting Stent System (XIENCE V) in the Treatment of Coronary Artery Lesions AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (07): : S20 - S21